Ivy Natal: Funding, Investors & Team (Oct 2026)
Many women cannot have children except through the use of donor eggs. This can be due to surgery, chemotherapy, age, or genetic conditions. We aim to allow these patients to have genetic children for the first time, using a process which starts with a simple skin biopsy. Our approach directly activates the skin cell’s existing DNA to transform it into a new, healthy egg cell. This avoids the challenges with traditional approaches to producing eggs and sperm in vitro. Our goal is to give women confidence in their ability to choose whether and when to have a child—and in the long term, ensure that every person and couple has the choice to have genetic children, including same-sex couples.
Ivy Natal has raised $1.5M across 1 funding round on record, the most recent an undisclosed round of $1.5M announced in Dec 2022.
That round is below the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Ivy Natal Company Profile and Key Stats
Latest funding round on record: Dec 2022.
Ivy Natal Funding Rounds
Ivy Natal Founders and Leadership Team
Contact details for the Ivy Natal team: 1 of 1 has an email address on file.
Start 14-day free trial →Ivy Natal Funding Compared to Other Biotechnology Startups
Ivy Natal's latest round of $1.5M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Ivy Natal in Biotechnology and San Francisco
Companies Similar to Ivy Natal
Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Ivy Natal Funding FAQs
What does Ivy Natal do?
Many women cannot have children except through the use of donor eggs. This can be due to surgery, chemotherapy, age, or genetic conditions. We aim to allow these patients to have genetic children for the first time, using a process which starts with a simple skin biopsy. Our approach directly activates the skin cell’s existing DNA to transform it into a new, healthy egg cell. This avoids the challenges with traditional approaches to producing eggs and sperm in vitro. Our goal is to give women confidence in their ability to choose whether and when to have a child—and in the long term, ensure that every person and couple has the choice to have genetic children, including same-sex couples.
How much funding has Ivy Natal raised?
Ivy Natal has raised $1.5M across 1 round on record. The most recent is an undisclosed round of $1.5M announced in Dec 2022.
When did Ivy Natal last raise funding?
Ivy Natal's most recent funding round on record is an undisclosed round of $1.5M, announced in Dec 2022.
Who founded Ivy Natal?
FundedIQ lists Jeffrey Hsu (Founder) at Ivy Natal.
Where is Ivy Natal headquartered?
Ivy Natal is based in San Francisco, California, United States.
How many employees does Ivy Natal have?
Ivy Natal is in the 1-10 employee band.
How does Ivy Natal's funding compare to other Biotechnology startups?
Ivy Natal's latest round of $1.5M is below the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Ivy Natal Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Ivy Natal is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.